Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Portugal and Spain or involving organisations from these countries.

Total search results: 353 | Ordered by Date (descending)
1 2 3 4  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Oryzon Genomics–Citigroup: investor conference, 201812 supply service Oryzon attends Citi Global Healthcare Conference NY 2018-12-05
Oryzon Genomics–Leucadia: investor conference, 201811 supply service Oryzon attends Jefferies London Healthcare Conference 2018 2018-11-14
Galecto Biotech–OrbiMed: investment, 201810 financing round Series C totalling $79m incl new + co-lead investor OrbiMed 2018-10-26
Galecto Biotech–SEVERAL: investment, 201810 financing round Series C €79m co-led by Ysios Capital + OrbiMed 2018-10-26
Galecto Biotech–Ysios Capital: investment, 201810 financing round Series C totalling $79m incl new + co-lead investor Ysios Capital 2018-10-26
Oryzon Genomics–SEVERAL: investment, 201810 private placement €13m w 4.96m new common shares at €2.62/share 2018-10-26
Minoryx–SEVERAL: investment, 201809 financing round Series B €21.3m led by Fund+ with SFPI + SRIW + Sambrinvest + all Series A investors 2018-09-26
Almirall–Evotec: drug discovery services, 201809– collab r+d therapies for dermatological diseases 2018-09-17
Grifols–EU (govt): credit, 201809–2028 loan €85m from European Investment Bank 2018-09-07
Molecular Discovery–Lead Molecular Design: mass spectrometry s/w, 201808 distribution existent of MetaSite + MassMetaSite et al by Molecular Discovery 2018-08-04
Waters–Molecular Discovery: mass spectrometry s/w, 201808– collab product integration MetaSite + MassMetaSite s/w with UNIFI Platform 2018-08-02
Laboratorios Ecosur–Eurofins: investment, 201807 acquisition of Ecosur by Eurofins 2018-07-27
Lunaphore–Vitro (ES): in situ hybridisation, 201805– collab developm ISH protocols for RNA + DNA targets in tissue 2018-05-24
Bionure–Alta Partners: investment, 201805 financing round Series A totalling €4m incl lead investor Alta Life Sciences 2018-05-16
Bionure–SEVERAL: investment, 201805 financing round Series A €4m led by Alta Life Sciences 2018-05-16
Reig Jofré–LeanBio: biosimilars, 201803– collab founding of joint venture Syna Therapeutics to develop biosimilars 2018-03-23
Aton–Grifols: investment, 201803– acquisition 100% of Haema for €220 on a debt free basis by Grifols from Aton GmbH 2018-03-20
Gain Therapeutics–SEVERAL: investment, 201802 investment spin-off of Minorix’ SEE-Tx platform as Gain Therapeutics with Swiss investors + TiVenture 2018-02-20
ABAC Therapeutics–SEVERAL: investment, 201802 financing round Series A €16m led by Pontifax + incl GHSF + Caixa Capital Risc + Debiopharm + Ferrer 2018-02-15
STAT-Diagnostica–Qiagen: investment, 201801 acquisition $147m upfront cash + $44m milestones of STAT-Dx by Qiagen 2018-01-31
Goetech–Grifols: investment, 201801 acquisition $98m of 51% stake in Goetech LLC (d/b/a MedKeeper) by Grifols 2018-01-26
Intelligent Pharma–Mind the Byte: investment, 201801 acquisition €na 100% of Intelligent Pharma by Mind the Byte 2018-01-11
Mind the Byte–SEVERAL: investment, 201801– financing round €3m (1/3 of company) to finance acquisition of Intelligent Pharma PLANNED 2018-01-11
Grifols–EU (govt): credit, 201712– loan €85m from European Investment Bank 2017-12-05
CLINGLIO project–EU (govt): grant, 201712–202011 Horizon 2020 grant €6.15m 3y for ph2 trial of 2OHOA in malignant glioma 2017-12-01
Irish Stock Exchange–Euronext: investment, 201711– acquisition €173m debt/cash free ANNOUNCED 2017-11-29
Mind the Byte–Prosilico: drug discovery + development software, 201711– collab co-promotion + product integration 2017-11-15
Mestrelab Research–SpectralWorks: analytical instrument software, 201708– collab mutual reseller agreem for all respective NMR/MS s/w products 2017-08-15
Evosciences–Danaher: mass spectrometer, 201707– distribution of Sciex MS systems with flexible finacing packages via Evosciences in Europe 2017-07-27
GigaGen–Grifols: investment, acquisition of 44% stake in GigaGen Inc for $35m in cash by Grifols 2017-07-05
FB Health–Invent Farma/Neuraxpharm: investment, 201706 acquisition €na of FB Health by Invent Farma/Neuraxpharm (formed 8/16 by Apax Partners) 2017-06-21
Oryzon Genomics–JMP Securities: investor conference, 201706 supply service Oryzon at JMP Securities 2017 Life Sciences Conference NY 2017-06-20
Medicxi Ventures–Alphabet: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–EU (govt): investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–Novartis: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–SEVERAL: investment, 201706 closing $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Pfizer–Basilea: isavuconazole, 201706– license CHF70m upfront + $427m milestones + royalties for prod + sales in Europe + RU + TR + IL 2017-06-14
Oryzon Genomics–Leucadia: investor conference, 201706 supply service Oryzon presents at Jefferies Healthcare Conference in New York 2017-06-09
Oryzon Genomics–Trout Group: public relations, 201705 service existent investor relations by Trout Group 2017-05-31
AptaTargets–Inveready: investment, 201705 financing round totalling €2.7m from Caixa Capital Risc + Inveready 2017-05-17
AptaTargets–la Caixa: investment, 201705 financing round totalling €2.7m from Caixa Capital Risc + Inveready 2017-05-17
AptaTargets–SEVERAL: investment, 201705 financing round €2.7m from Caixa Capital Risc + Inveready 2017-05-17
Specialised Therapeutics Australia–PharmaMar: lurbinectedin, 201705– license to market lurbinectedin in AU + NZ + 12 Asian countries for STA 2017-05-17
Mind the Byte–SEVERAL: investment, 201705–201707 financing round €300k via crowdfunding platform Crowdcube 2017-05-09
Genetrix (ES)–SEVERAL: investment, 201705– capital increase up to €10m w rights offering + private placement Sygnis AG 2017-05-08
Innova Biosciences–Genetrix (ES): investment, 201705–201707 acquisition €8m cash + 2m Sygnis shares plus up to 1.5m shares by Sygnis AG 2017-05-08
Celyad–Deutsche Bank: investor conference, 201705 supply service Celyad presents at Deutsche Bank Annual Health Care Conference 2017-05-04
Vivet Therapeutics–Columbus Venture Partners: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor CVP 2017-05-04
Vivet Therapeutics–Huntsworth: public relations, 201705 service existent by Citigate Dewe Rogerson 2017-05-04
Vivet Therapeutics–Kurma: investment, 201705 financing round Series A totalling €37.5m incl co-investor Kurma Partners 2017-05-04
Vivet Therapeutics–Novartis: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor Novartis Venture Fund 2017-05-04
Vivet Therapeutics–Odlander Fredrikson: investment, 201705 financing round Series A totalling €37.5m incl co-investor HealthCap 2017-05-04
Vivet Therapeutics–Roche: investment, 201705 financing round Series A totalling €37.5m incl co-investor Roche Venture Fund 2017-05-04
Vivet Therapeutics–SEVERAL: investment, 201705 financing round Series A €37.5m led by Novartis Venture Fund + Columbus Venture Partners 2017-05-04
Vivet Therapeutics–Ysios Capital: investment, 201705 financing round Series A totalling €37.5m incl co-investor Ysios Capital 2017-05-04
EMBL–Enamine: chemical compound library, 201704– collab library synthesis + medical chemistry + biological services for cancer drug research 2017-04-25
Oryzon Genomics–SEVERAL: investment, 201703 private placement €18.2m w 5.7m news common shares at €3.2/share 2017-03-31
Versantis–SEVERAL: investment, 201703 financing round Series A CHF4.4m led by Redalpine Venture Partners 2017-03-29
BioClin Therapeutics–Life Sciences Partners: investment, 201703 financing round Series B totalling $30m incl existing investor LSP 2017-03-22
BioClin Therapeutics–Odlander Fredrikson: investment, 201703 financing round Series B totalling $30m incl existing investor HealthCap 2017-03-22
BioClin Therapeutics–SEVERAL: investment, 201703 financing round Series B $30m led by new investors Sofinnova Ventures + Ysios Capital 2017-03-22
BioClin Therapeutics–Sofinnova: investment, 201703 financing round Series B totalling $30m led by new investors Sofinnova Ventures + Ysios Capital 2017-03-22
BioClin Therapeutics–Tekla Capital: investment, 201703 financing round Series B totalling $30m incl existing investor Tekla Capital Management 2017-03-22
BioClin Therapeutics–Ysios Capital: investment, 201703 financing round Series B totalling $30m led by new investors Sofinnova Ventures + Ysios Capital 2017-03-22
Imegen (ES)–SEVERAL: investment, 201703 acquisition €10m of majority share in Imegen by Q-Growth Fund + Biolty 2017-03-16
MedLumics–LCF Rothschild: investment, 201703 investment by EdRIP 2017-03-01
Prexton Therapeutics–Forbion: investment, 201702 financing round Series B totalling €29m co-led by new investors Forbion + Seroba 2017-02-07
Prexton Therapeutics–Merck (DE): investment, 201702 financing round Series B totalling €29m incl returning co-investor Merck Ventures 2017-02-07
Prexton Therapeutics–Seroba: investment, 201702 financing round Series B totalling €29m co-led by new investors Forbion + Seroba 2017-02-07
Prexton Therapeutics–SEVERAL: investment, 201702 financing round Series B €29m co-led by new investors Forbion + Seroba 2017-02-07
Prexton Therapeutics–Sunstone Capital: investment, 201702 financing round Series B totalling €29m incl returning co-investor Sunstone Capital 2017-02-07
Prexton Therapeutics–Ysios Capital: investment, 201702 financing round Series B totalling €29m incl returning co-investor Ysios Capital 2017-02-07
Villapharma Research–Eurofins: investment, 201612– acquisition of Villapharma by Eurofins ANNOUNCED 2016-12-29
C.B.S. Scientific–Genetrix (ES): investment, 201612 acquisition $900k of C.B.S. Scientific Company for $540k cash + $360k in shares by Sygnis AG 2016-12-21
Hologic–Grifols: investment, 201612 agreem for Grifols to acquire Hologic’s interest in joint NAT donor screening business for $1.85b 2016-12-14
EURE-CART project–EU (govt): grant, 201612c– Horizon 2020 grant €5.9m 4y for clinical research on CART T-cell immunotherapy 2016-12-12
MolMed–EU (govt): grant, 201612c– Horizon 2020 grant €2m for MolMed for 4y as coordinator of EURE-CART project 2016-12-12
Biopremier (PT)–SGS: investment, 201612 acquisition of 70% stake by SGS 2016-12-09
Genetrix (ES)–GBC: investor conference, 201612 supply service Sygnis AG presents at MKK Münchner Kapitalmarkt Konferenz 2016 2016-12-07
OxThera–SEVERAL: investment, 201611 financing round €32m co-led by Life Sciences Partners + Ysios Capital + Sunstone Capital + Flerie Invest 2016-11-29
Neovacs–Infarco: biologics contract manufacturing, 201611– supply of IFNalpha by 3P Biopharmaceuticals to Neovacs 2016-11-23
Genetrix (ES)–Deutsche Börse: investor conference, 201611 supply service Sygnis AG presents at Deutsches Eigenkapitalforum 2016 2016-11-21
CorWave–SEVERAL: investment, 2013 financing round Series A 2016-11-04
CorWave–SEVERAL: investment, 201611 financing round Series B €15.5m led by new investor Novo Seeds 2016-11-04
Iproteos–SEVERAL: investment, 201610 financing round €1.5m led by Caixa Capital Risc + co-investors Kinled Holding + Ascil Biopharm 2016-10-25
Aura Biosciences–Ysios Capital: investment, 201610 existent investment of Ysios BioFund II Innverite FCR 2016-10-18
Megalab (ES)–Eurofins: investment, 201609 acquisition €40m of Megalab SA by Eurofins 2016-09-30
Oryzon Genomics–SEVERAL: credit, 201610 long-term loans €5.3m from Spanish commerical banks at current interest rates 2016-09-26
Oryzon Genomics–Informa: partnering conference, 201611 supply service Oryzon Presents at BioPharm America 2016 in Boston 2016-09-13
Oryzon Genomics–Rodman & Renshaw: investor conference, 201609 supply service Oryzon presents at Rodman & Renshaw Global Investment Conference in NY 2016-09-11
Oncovision–Bruker Corp: investment, 201609 acquisition €na of preclinical imaging business of Oncovision by Bruker 2016-09-07
DiViNe project–Affilogic: vaccine purification technology, 201609 collab Affilogic is partner in Horizon 2020 project led by iBET 2016-09-01
DiViNe project–Aquaporin: vaccine purification technology, 201609 collab Aquaporin is partner in Horizon 2020 project led by iBET 2016-09-01
DiViNe project–EU (govt): grant, 201609c– Horizon 2020 grant 5y to advance vaccine purification led by iBET 2016-09-01
DiViNe project–GSK: vaccine purification technology, 201609 collab GSK Italy is partner in Horizon 2020 project led by iBET 2016-09-01
DiViNe project–iBET (PT): vaccine purification technology, 201609 collab GenIbet + iBET are partners in Horizon 2020 project led by iBET 2016-09-01
DiViNe project–Merck (DE): vaccine purification technology, 201609– collab Merck is partner in Horizon 2020 project led by iBET 2016-09-01
Thomson Reuters–Onex Corp: investment, 201607–201610 acquisition $3.55b in cash of Thomson Reuters IP + Science business by Onex + Baring PE Asia 2016-07-11
Nicox–GHO Capital: investment, 201607– acquisition €26m with €9m cash + €12m shares+loan notes + €5m milestones of Nicox commercial operations by GHO 2016-07-05
MetaSUB project–Qiagen: genomic sample preparation, 201606– collab project using Qiagen sample tech + library prepration workflows 2016-06-21
1 2 3 4  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px

» top